Motion Style Slider: novel framework enabling fine control of nuances in character motion
Reports and Proceedings
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 3-Nov-2026 04:16 ET (3-Nov-2026 09:16 GMT/UTC)
Novel framework enables fine control over the intensity and expressiveness of AI-generated human motion, as reported by researchers from Science Tokyo. The “Motion Style Slider” framework enables animators to control the style and adjust a virtual character’s motion, from subtle to overly exaggerated, based on only two motion samples. The proposed approach achieves consistent style control and smooth transitions without the need for extensive motion-capture datasets.
Schooling fish have long fascinated us with their mesmerizing collective movements and seemingly perfect coordination. But a new study on clonal mollies suggests that this behavior is not innate. During their first days of life, the fish still display distinct individual behaviors, and it is only around one month of age that they begin to form cohesive shoals, developing the coordinated movements characteristic of the group. However, several shoals of genetically identical clones begin to behave differently after a few weeks. The study was conducted by the Cluster of Excellence ‘Science of Intelligence (SCIoI)’, the Leibniz Institute of Freshwater Ecology and Inland Fisheries (IGB), Humboldt Universität zu Berlin, and UC Davis and published in Current Biology.
The Novo Nordisk Foundation has committed $53 million to renew and expand the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease at the Broad Institute, led by managing director Kasper Lage. This funding will scale up the Center's transatlantic efforts to decode the biological drivers of type 2 diabetes and obesity and identify new targets for potential therapies by combining massive-scale data generation, artificial intelligence, and advanced cellular models.
Researchers at the Icahn School of Medicine at Mount Sinai have developed an artificial intelligence (AI) approach using data from wearable devices that can forecast upcoming periods of prolonged sitting in women with chronic pelvic pain disorders. The findings, published in the September 30 online issue of npj Women’s Health [DOI: 10.1038/s44294-026-00156-5], could inform personalized digital health tools that prompt the individual to move, such as by taking a short walk, at the right time while minimizing unnecessary alerts.
A new framework developed by SUTD researchers could improve how robots, autonomous systems and augmented reality tools recognise objects and navigate complex real-world environments.
Researchers at Chalmers University of Technology in Sweden have developed an AI scientist capable of generating scientific hypothesis, designing experiments, and interpreting results. Making new biological discoveries with minimal human intervention is an important advance in self-driving laboratories.Researchers at Chalmers University of Technology in Sweden have developed an AI scientist capable of generating scientific hypothesis, designing experiments, and interpreting results. Making new biological discoveries with minimal human intervention is an important advance in self-driving laboratories.
October 6–7 | Abu Dhabi
Dr. Alex Aliper, Co-founder and President of Insilico Medicine, has been invited to speak at the AI Everything Abu Dhabi summit.October 7–9 | Yokohama, Japan
Insilico Medicine will make an appearance at BioJapan 2026, held from October 7 to 9 at PACIFICO Yokohama, at Booth D74.October 7–11 | San Francisco
Dr. Alex Zhavoronkov, Founder and Co-CEO of Insilico Medicine, has been invited to attend the Abundance Longevity Trip, founded by Dr. Peter Diamandis.